PCMA on New Bureau of Labor Statistics Data: Competition is the Key to Lowering High Drug Prices
October 19, 2016
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement regarding drug price...
August 25, 2016
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on Mylan’s EpiPen price hikes and...
PCMA: CREATES Act to Increase Access to Generic Drugs
June 21, 2016
(Washington, D.C.) — Today’s Senate Judiciary Subcommittee hearing on S. 3056, the Creating and Restoring Equal Access to Equivalent Samples...
New Report: New Incentives for Physicians to Prescribe Biosimilars Would Improve Affordability
April 15, 2016
(Washington, D.C.)—Incentives for physicians to prescribe biosimilars could increase utilization and reduce costs, according to a new report — “Payor...
PCMA Statement on the FDA’s Decision to Approve the Second U.S. Biosimilar
April 06, 2016
(Washington, D.C.)—Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on yesterday’s decision by the...